Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
Ming Chen(Michigan State University), Anna Moore(Michigan State University)
Cited by 14